Ads
related to: pfizer
Search results
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 7 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday ...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 10 hours agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 15 hours agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 9 hours agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The FDA...
Pfizer Files Flurry of Lawsuits Over Migraine Medication Patent | Delaware Law Weekly
Law.com· 3 days agoPfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication ...
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?
The Motley Fool via AOL· 4 days agoThe benchmark index is way up, but not all of its components have participated in the rally. Shares of Pfizer (NYSE: PFE) and Walgreens Boots Alliance (NASDAQ: WBA) have been ...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 11 hours agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
CNBC· 1 day agoThe company last week released a free new tool set called the AI Trust and Assurance Suite, which...
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 6 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There are dozens of innovative ...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 7 hours agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...